Assistant Professor in Obstetrics and Gynecology
Obstetrics & Gynecology
Dr. Lisa M. Landrum, MD
|
|
Give Review
Lisa Landrum works in the field of Obstetrics & Gynecology. She studied medicine at University of Oklahoma College of Medicine. She has 1 awards "Fellow (FACOG)". Dr. Lisa M. Landrum is a published physician. She has 26 publications published. The most current publication "Does postsynaptic alpha 1-adrenergic receptor supersensitivity contribute to autonomic dysreflexia?" She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncolo...
- Bevacizumab for advanced Cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
- Comprehensive care in gynecologic oncology: The importance of palliative care.
- Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian Cancer.
- Pemetrexed and Cisplatin for the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix: A Limited Access Phase II Trial of the Gynecologic Oncology G...
- Improved survival with bevacizumab in advanced Cervical cancer.
- A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal Carcinoma: A Gyneco...
- Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial Cancer patients with high-intermediate risk factors.
- Prognostic factors for stage III epithelial ovarian Cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study.
- Patterns of recurrence in stage I endometrioid endometrial adenoCarcinoma with lymphovascular space invasion.
- Tubal ligation frequency in Oklahoma women with Cervical cancer.
- Clinical and pathological heterogeneity of Cervical intraepithelial neoplasia grade 3.
- Evaluation of the diagnostic accuracy of the risk of Ovarian malignancy algorithm in women with a pelvic mass.
- Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube Cancer.
- Adjuvant chemotherapy for the "oldest old" ovarian Cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
- Stage IVB endometrial Cancer: does applying an ovarian Cancer treatment paradigm result in similar outcomes? A case-control analysis.
- Ovarian Cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
- Comparison of outcome measures in patients with advanced squamous cell Carcinoma of the vulva treated with surgery or primary chemoradiation.
- Intraperitoneal chemotherapy for patients with advanced epithelial ovarian Cancer: a review of complications and completion rates.
- Uterine leiomyoma with associated pseudo-Meigs syndrome mimicking ovarian Carcinoma.
- Gynecologic Oncology Group risk groups for vulvar Carcinoma: improvement in survival in the modern era.
- The expression of Fos-labeled spinal neurons in response to colorectal distension is enhanced after chronic spinal cord transection in the rat.
- Does postsynaptic alpha 1-adrenergic receptor supersensitivity contribute to autonomic dysreflexia?
- Pneumococcal meningitis during pregnancy: a case report and review of literature.
- A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive Ovarian, primary peritoneal, and fall...
Schools
University of Oklahoma Health Sciences Center
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- Dilation and Curettage
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Cervicitis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
U Oklahoma -
University of Oklahoma Health Sciences Center -
University of Oklahoma College of Medicine
Hospital
-
Mercy Hospital Oklahoma City
Drug Facts
| NPI NUMBER | 1356456438 | |
| NPPES Provider LastName | LANDRUM | |
| NPPES Provider FirstName | LISA | |
| NPPES Provider ZIPCode | 731045417 | |
| NPPES Provider State | OK | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 384.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 40.0 | |
| Percent Opioid Claims | 10.42 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356456438 |
| Last Name Of The Provider | LANDRUM |
| First Name Of The Provider | LISA |
| View All |
Similar Doctors
|
Dr. Jeffrey J. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan L. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Mannel, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Pablo A. Pinzon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry Houk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauranne Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen N. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine A. Gazzaniga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Ryker Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald S. McMeekin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy Fong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kaitlin Hoover, MD
This Doctor is OpenDoctor Recommended.
|